Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction
- PMID: 33800220
- PMCID: PMC7962533
- DOI: 10.3390/ijms22052715
Macrophage Polarization in Cardiac Tissue Repair Following Myocardial Infarction
Abstract
Cardiovascular disease is the leading cause of mortality and morbidity around the globe, creating a substantial socio-economic burden as a result. Myocardial infarction is a significant contributor to the detrimental impact of cardiovascular disease. The death of cardiomyocytes following myocardial infarction causes an immune response which leads to further destruction of tissue, and subsequently, results in the formation of non-contractile scar tissue. Macrophages have been recognized as important regulators and participants of inflammation and fibrosis following myocardial infarction. Macrophages are generally classified into two distinct groups, namely, classically activated, or M1 macrophages, and alternatively activated, or M2 macrophages. The phenotypic profile of cardiac macrophages, however, is much more diverse and should not be reduced to these two subsets. In this review, we describe the phenotypes and functions of macrophages which are present in the healthy, as well as the infarcted heart, and analyze them with respect to M1 and M2 polarization states. Furthermore, we discuss therapeutic strategies which utilize macrophage polarization towards an anti-inflammatory or reparative phenotype for the treatment of myocardial infarction.
Keywords: cardiac tissue repair; macrophage polarization; macrophages; myocardial infarction.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.Eur J Pharmacol. 2019 Jul 5;854:307-319. doi: 10.1016/j.ejphar.2019.04.046. Epub 2019 Apr 27. Eur J Pharmacol. 2019. PMID: 31039343
-
Caveolin-1 deletion exacerbates cardiac interstitial fibrosis by promoting M2 macrophage activation in mice after myocardial infarction.J Mol Cell Cardiol. 2014 Nov;76:84-93. doi: 10.1016/j.yjmcc.2014.07.020. Epub 2014 Aug 12. J Mol Cell Cardiol. 2014. PMID: 25128086 Free PMC article.
-
Role of Macrophages in Cardioprotection.Int J Mol Sci. 2019 May 19;20(10):2474. doi: 10.3390/ijms20102474. Int J Mol Sci. 2019. PMID: 31109146 Free PMC article. Review.
-
Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.J Mol Cell Cardiol. 2017 Jul;108:42-49. doi: 10.1016/j.yjmcc.2016.05.016. Epub 2016 Jun 1. J Mol Cell Cardiol. 2017. PMID: 27262672
-
Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches.Int Immunopharmacol. 2024 Dec 25;143(Pt 3):113562. doi: 10.1016/j.intimp.2024.113562. Epub 2024 Nov 12. Int Immunopharmacol. 2024. PMID: 39536484 Review.
Cited by
-
Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction.J Cardiovasc Transl Res. 2024 Apr;17(2):356-375. doi: 10.1007/s12265-023-10438-x. Epub 2023 Oct 11. J Cardiovasc Transl Res. 2024. PMID: 37819538 Review.
-
Exosomes in Myocardial Infarction: Therapeutic Potential and Clinical Application.J Cardiovasc Transl Res. 2023 Feb;16(1):87-96. doi: 10.1007/s12265-022-10284-3. Epub 2022 Jun 7. J Cardiovasc Transl Res. 2023. PMID: 35672604 Review.
-
Modulation of anti-cardiac fibrosis immune responses by changing M2 macrophages into M1 macrophages.Mol Med. 2024 Jun 15;30(1):88. doi: 10.1186/s10020-024-00858-z. Mol Med. 2024. PMID: 38879491 Free PMC article.
-
Are There Hopeful Therapeutic Strategies to Regenerate the Infarcted Hearts?Korean Circ J. 2023 Jun;53(6):367-386. doi: 10.4070/kcj.2023.0098. Korean Circ J. 2023. PMID: 37271744 Free PMC article. Review.
-
Cardiac fibrogenesis: an immuno-metabolic perspective.Front Physiol. 2024 Mar 21;15:1336551. doi: 10.3389/fphys.2024.1336551. eCollection 2024. Front Physiol. 2024. PMID: 38577624 Free PMC article. Review.
References
-
- Roth G.A., Abate D., Abate K.H., Abay S.M., Abbafati C., Abbasi N., Abbastabar H., Abd-Allah F., Abdela J., Abdelalim A. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7. - DOI - PMC - PubMed
-
- Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N. Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
-
- American Heart Association . Cardiovascular Disease: A Costly Burden for America Projections through 2035. American Heart Association; Washington, DC, USA: 2017.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical